Therapeutic responses and prognosis in adult-onset Still's disease

Rheumatology International

Volumn 32, Issue 5, 2012, Pages 1291-1298

  Kim, Hyoun Ah ^a   Sung, Jun Mo ^a   Suh, Chang Hee ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Adult onset Still's disease; Corticosteroids; Intravenous immunoglobulin; Methotrexate; Prognosis; Treatment

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; MINOCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; ADULT ONSET STILL DISEASE; ARTICLE; BONE DISEASE; CLINICAL FEATURE; DRUG MEGADOSE; DRUG RESISTANCE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADRENAL CORTEX HORMONES; ADULT; AGE FACTORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD SEDIMENTATION; CHI-SQUARE DISTRIBUTION; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STILL'S DISEASE, ADULT-ONSET; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84863629356     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1801-6     Document Type: Article

References (39)

1. Bywaters EG (1971) Still's disease in the adult. Ann Rheum Dis 30:121-133
2. Fautrel B (2008) Adult-onset Still disease. Best Pract Res Clin Rheumatol 22:773-792
3. Ohta A, Yamaguchi M, Kaneoka H et al (1987) Adult Still's disease: review of 228 cases from the literature. J Rheumatol 14:1139-1146
4. Pouchot J, Sampalis JS, Beaudet F et al (1991) Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 70:118-136
5. Cagatay Y, Gul A, Cagatay A et al (2009) Adult-onset Still's disease. Int J Clin Pract 63:1050-1055
6. Efthimiou P, Kontzias A, Ward CM et al (2007) Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy? Nat Clin Pract Rheumatol 3:328-335
7. Magadur-Joly G, Billaud E, Barrier JH et al (1995) Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis 54:587-590
8. Wakai K, Ohta A, Tamakoshi A et al (1997) Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan. J Epidemiol 7:221-225
9. Coffernils M, Soupart A, Pradier O et al (1992) Hyperferritinemia in adult onset Still's disease and the hemophagocytic syndrome. J Rheumatol 19:1425-1427
10. Reginato AJ, Schumacher HR Jr, Baker DG et al (1987) Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum 17:39-57
11. Hirohata S, Kamoshita H, Taketani T et al (1986) Adult Still's disease complicated with adult respiratory distress. Arch Intern Med 146:2409-2410
12. Akritidis N, Sakkas LI (1995) Adult onset Still's disease. 16 cases. Presse Med 24:1207-1208
13. Andres E, Kurtz JE, Perrin AE et al (2003) Retrospective monocentric study of 17 patients with adult Still's disease, with special focus on liver abnormalities. Hepatogastroenterology 50:192-195
14. Evensen KJ, Nossent HC (2006) Epidemiology and outcome of adult-onset Still's disease in Northern Norway. Scand J Rheu-matol 35:48-51
15. Chen DY, Lan JL, Hsieh TY et al (2004) Clinical manifestations, disease course, and complications of adult-onset Still's disease in Taiwan. J Formos Med Assoc 103:844-852
16. Ohta A, Yamaguchi M, Tsunematsu T et al (1990) Adult Still's disease: a multicenter survey of Japanese patients. J Rheumatol 17:1058-1063
17. Uppal SS, Pande IR, Kumar A et al (1995) Adult onset Still's disease in northern India: comparison with juvenile onset Still's disease. Br J Rheumatol 34:429-434
18. Cush JJ, Medsger TA Jr, Christy WC et al (1987) Adult-onset Still's disease. Clinical course and outcome. Arthritis Rheum 30:186-194
19. Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
20. Pay S, Turkcapar N, Kalyoncu M et al (2006) A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol 25:639-644
21. Zeng T, Zou YQ, Wu MF et al (2009) Clinical features and prognosis of adult-onset still's disease: 61 cases from China. J Rheumatol 36:1026-1031
22. Fitzgerald AA, Leclercq SA, Yan A et al (2005) Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum 52:1794-1803
23. Fautrel B, Sibilia J, Mariette X et al (2005) Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis 64:262-266
24. Kokkinos A, Iliopoulos A, Greka P et al (2004) Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol 23:45-49
25. Benucci M, Li GF, Del Rosso A et al (2005) Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: the first case report. Clin Exp Rheumatol 23:733
26. Efthimiou P, Georgy S (2006) Pathogenesis and management of adult-onset Still's disease. Semin Arthritis Rheum 36:144-152
27. Maier J, Birkenfeld G, Pfirstinger J et al (2008) Effective treatment of steroid refractory adult-onset Still's disease with ana-kinra. J Rheumatol 35:939-941
28. Lequerre T, Quartier P, Rosellini D et al (2008) Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France. Ann Rheum Dis 67:302-308
29. Naumann L, Feist E, Natusch A et al (2010) IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease. Ann Rheum Dis 69:466-467
30. Kotter I, Wacker A, Koch S et al (2007) Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthritis Rheum 37:189-197
31. Mahmud T, Hughes GR (1999) Intravenous immunoglobulin in the treatment of refractory adult Still's disease. J Rheumatol 26:2067-2068
32. Permal S, Wechsler B, Cabane J et al (1995) Treatment of Still disease in adults with intravenous immunoglobulins. Rev Med Interne 16:250-254
33. Vignes S, Wechsler B, Amoura Z et al (1998) Intravenous immunoglobulin in adult Still's disease refractory to non-steroi-dal anti-inflammatory drugs. Clin Exp Rheumatol 16:295-298
34. Efthimiou P, Paik PK, Bielory L (2006) Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 65:564-572
35. Kraetsch HG, Antoni C, Kalden JR et al (2001) Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences. Ann Rheum Dis 60:55-57
36. Husni ME, Maier AL, Mease PJ et al (2002) Etanercept in the treatment of adult patients with Still's disease. Arthritis Rheum 46:1171-1176
37. Fautrel B, Borget C, Rozenberg S et al (1999) Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease. J Rheumatol 26:373-378
38. Fujii T, Akizuki M, Kameda H et al (1997) Methotrexate treatment in patients with adult onset Still's disease-retrospective study of 13 Japanese cases. Ann Rheum Dis 56:144-148
39. Kontzias A, Efthimiou P (2008) Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances. Drugs 68:319-337